Laboratory Testing for the Diagnosis of Inflammatory Bowel Disease
This policy governs reimbursement for laboratory tests and diagnostic algorithm–based panels used in the diagnosis and monitoring of IBD for Blue Cross Blue Shield of Texas members; it affects providers submitting claims for those services.
Added code 0598U effective 10/01/2025.
Reimbursement information revised to include ibs-smart™ as example in #2.
Document updated with literature review and references revised.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.